- Coronary Stents Coronary Balloons Catheters Guide Wires Introducer Sheaths Fractional Flow Reserve Accessories Peripheral Interventional Products Structural Heart Diseases Products 12345678
- Pacemakers and Leads Equipments
- Needle-free Connectors CVC Accessories
- Dialyzer Hemoperfutor Hemodialysis Accessories
- POCT Point of Care Testing Immunoassay Molecular Diagnostics Biochemistry Hematology Diagnostics
- ECG Patient Monitor Oximeter
- Cardiovasculars Oncology Anti-infectives Central Nervous System Others
- Surgical Staplers Endoscopy Endoscopic Ultrasound System
- Trauma Implant Spinal Implant Joint System Surgical Instruments
- Colloidal Gold Quantitative Analyzer SARS-CoV-2 Test Kits 2019-nCoV Neutralization Antibody Test Kit Poctor® blood glucose, ketone body, uric acid detector Cholesterol Analyzer PT/INR Meter
- Fully Automated ELISA workstation Immunofluorescence Quantitative Analyzer Fully Automated CLIA workstation Automatic fluorescence immunoassay analyzer Other Platforms
- Fully Automated Nucleic Acid Extractor Nucleic Acid Extraction or Purification Kit Real-Time PCR System
- Thromboelastography Analyzer Fully automated blood grouping system
- NeoECG Holter Monitor Portable ECG Monitor OmniECG AI-ECG Pocket ECG
- Patient Monitor Vital Signs Monitor End-tidal Capnography
- Fingertip Oximeter Handheld Oximeter Wrist Oximeter Wearable Oximeter All-in-One Health Monitor POCT Solution
- Locking Compression Plates System Locking Plates Screws Interlocking Intramedullary Nails System Mini Plates System Conventional Plates Metal Pins Dynamic Hip Locking Plate
- Anterior Cervical Locking Fixation System Laminoplasty Plate Fixation System Internal Spinal Fixation System Spinal Fusion System
- Instrument Set of Arthroplasty System
Nano+ Polymer-free Sirolimus-eluting Coronary Stent System Details
Product Description
Nanoporous cavities on strut abluminal surface functioning as drug carrier to ensure the firm adhesion.
Vacuum drug coating technology ensures complete drug dosage and coating stability.
Post-treatment after drug loading helps with sustained drug release.
Soft tapered tip provides smooth transition from guidewire to balloon catheter and excellent crossability.
Short shoulder design at both ends of the balloon ensures the accurate dilation to the lesion, and reduces the damage to normal vessel next to the lesion.
Patented hydrophilic coating on distal shaft provides outstanding pushability.
Polymer-free design significantly reduces the inflammatory response after stent implantation to guarantee the long-term safety.
Polymer-free design facilitates earlier endothelialization which significantly shorten the DAPT time.
The rough strut surface helps with earlier and easier endothelialization to reduce the risk of thrombosis.
DES Efficacy [1]
BMS Safety [2]
Nano+™ OCT Study
An OCT Study in Europe Shows Nano+™ A Great Combination of DES Efficacy and BMS Safety
Prouduct Features
Polymer-free DES
Nanoporous drug carrier on abluminal surface
Balanced strut thickness
High radial force
Sine wave + 3-3-3 link
Double helix structure
Large open cell
Precise positioning markers
Effective drug of Sirolimus
Vacuum drug coating technology
90-day drug releasing period
New delivery system
Prouduct Benefits
Significantly shorten DAPT time
Earlier & better endothelialization
Highly reduced risk of thrombosis
Great deliverability
Easy positioning and placement
Optimal tissue scaffolding
Excellent side branch access
Scientific drug releasing period
Prouduct Ranges
Ø 2.5 - 4.0 mm
12 - 36 mm multi stent lengths
Clinical Studies
An OCT Study in Europe Shows Nano+™ A Great Combination of DES Efficacy and BMS Safety [3].
In a prospective, multicentre, single-arm, open-label study, OCT examinations
were performed at three months in 45 patients (47 lesions). 23 patients with 24 lesions
had serial coronary angiography and OCT assessment at three and six months.
OCT Analyses
Coverage status of the individual stents/patients at two time points (three and six months).
Serial OCT showed almost complete vascular healing at six months, even when coverage was insufficient at three months. This suggests an adequate safety and efficacy profile of the device at that point in time.
Specifications
Ordering Information
Please contact us for detailed information in your country.
Thank You for Your Attention on Lepu Medical!
Email us with any questions or inquiries or use our contact data. We would be happy to answer your questions.
